Filing Details

Accession Number:
0001179110-10-003125
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-18 12:00:00
Reporting Period:
2010-02-16
Filing Date:
2010-02-18
Accepted Time:
2010-02-18 18:01:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1298968 C John Landgraf 100 Abbott Park Road
Abbott Park IL 60064-6400
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Disposition 2010-02-16 5,060 $53.93 79,749 No 4 F Direct
Common Shares Without Par Value Disposition 2010-02-16 1,700 $53.91 78,049 No 4 S Direct
Common Shares Without Par Value Disposition 2010-02-17 100 $54.88 77,949 No 4 S Direct
Common Shares Without Par Value Disposition 2010-02-17 2,100 $54.88 75,849 No 4 S Direct
Common Shares Without Par Value Disposition 2010-02-17 8,040 $54.88 67,809 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares Without Par Value 16,401 Indirect Profit Sharing Trust
Common Shares Without Par Value 30,000 Indirect Anne Marie Landgraf Living Trust
Common Shares Without Par Value 1,602 Indirect By self for son
Footnotes
  1. Balance in the Abbott Laboratories Stock Retirement Trust as of February 15, 2010.
  2. Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.
  3. Includes shares acquired under the Abbott Laboratories Dividend Re-investment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.
  4. Reporting person disclaims beneficial ownership of all securities held by his son.